Christopher Shen

Christopher Shen joined Novo Holdings in 2024 as Partner on the U.S. Ventures Team.

He brings 20+ years of global healthcare investment experience. Prior to Novo, Chris was a Managing Director at CBC Group, where he focused on US/Europe/Asia medical technology investments. Previously, he co-founded the US healthcare venture investing arms at Temasek/Vertex Healthcare and Qiming Venture Partners. He began his investment career at New Enterprise Associates. Chris initially transitioned from clinical medicine to industry working as a Senior Design Engineer at Guidant Corporation, where he was the principal inventor on one of the earliest stentriever devices for ischemic stroke.

Chris is also an Adjunct Professor of Medicine at Stanford University, responsible for training and mentoring international and Stanford-based faculty and students in medical technology innovation.

Chris received his MD, MBA, and MS Biomechanical Engineering from Stanford University.